Ra Medical: Catheter Precision System Used in Over 800 Procedures in US, Euro Hospitals

 -Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that more than 800 procedures have been performed in a number of leading U.S. and European hospitals utilizing the VIVO System that enables physicians to noninvasively identify an area of ventricular arrhythmia onset. On September 12, 2022 privately held Catheter Precision announced a definitive merger agreement with Ra Medical Systems (NYSE American: RMED), which, if completed, will result in a combined publicly traded company focusing on the cardiac electrophysiology market.

https://www.businesswire.com/news/home/20221201005454/en/Catheter-Precision%E2%80%99s-VIVO%E2%84%A2-System-Used-in-More-Than-800-Procedures-in-Leading-U.S.-and-European-Hospitals